Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — Cash Flow Reinvestment Rate
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a Cash Flow Reinvestment Rate of 0.29x as of March 2023, reinvesting €54.13 Million (capex €44.48 Million plus investments €9.65 Million) from operating cash flow of €186.97 Million. Explore 2TZ capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited across 12 annual periods. Also explore Tianjin Zhong Xin Pharmaceutical Group C balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2025)
Year-by-year capital reinvestment analysis for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited. For live market cap and broader valuation context, see market value of Tianjin Zhong Xin Pharmaceutical Group C.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.05x | €1.41 Billion | €461.07 Million | €118.61 Million | ▲ +205.1% |
| 2024 | 1.00x | €925.65 Million | €924.67 Million | €117.81 Million | ▼ -2.9% |
| 2023 | 1.03x | €709.84 Million | €688.49 Million | €140.93 Million | ▲ +481.0% |
| 2022 | 0.18x | €120.18 Million | €677.25 Million | €107.90 Million | ▼ -69.2% |
| 2021 | 0.58x | €491.87 Million | €852.40 Million | €156.95 Million | ▲ +68.3% |
| 2020 | 0.34x | €230.21 Million | €671.42 Million | €189.16 Million | ▼ -44.1% |
| 2019 | 0.61x | €303.67 Million | €495.49 Million | €205.61 Million | ▼ -62.9% |
| 2018 | 1.65x | €578.87 Million | €350.14 Million | €175.81 Million | ▲ +237.4% |
| 2016 | 0.49x | €204.73 Million | €417.77 Million | €116.20 Million | ▼ -61.4% |
| 2015 | 1.27x | €457.26 Million | €360.58 Million | €92.64 Million | ▲ +116.0% |
| 2014 | 0.59x | €168.37 Million | €286.85 Million | €70.15 Million | ▼ -63.7% |
| 2013 | 1.61x | €344.69 Million | €213.44 Million | €72.42 Million | — |